571 related articles for article (PubMed ID: 16136016)
21. A review of agitation in mental illness: treatment guidelines and current therapies.
Marder SR
J Clin Psychiatry; 2006; 67 Suppl 10():13-21. PubMed ID: 16965191
[TBL] [Abstract][Full Text] [Related]
22. The emergency treatment of depression complicated by psychosis or agitation.
Glick RL; Ghaemi SN
J Clin Psychiatry; 2000; 61 Suppl 14():43-8. PubMed ID: 11154016
[TBL] [Abstract][Full Text] [Related]
23. Pharmacologic interventions for psychosis and agitation in neurodegenerative diseases: evidence about efficacy and safety.
Weintraub D; Katz IR
Psychiatr Clin North Am; 2005 Dec; 28(4):941-83, ix-x. PubMed ID: 16325736
[No Abstract] [Full Text] [Related]
24. Parenteral ziprasidone: a new atypical neuroleptic for emergency treatment of psychosis in Parkinson's disease?
Oechsner M; Korchounov A
Hum Psychopharmacol; 2005 Apr; 20(3):203-5. PubMed ID: 15799011
[TBL] [Abstract][Full Text] [Related]
25. Comparison of intramuscular olanzapine, orally disintegrating olanzapine tablets, oral risperidone solution, and intramuscular haloperidol in the management of acute agitation in an acute care psychiatric ward in Taiwan.
Hsu WY; Huang SS; Lee BS; Chiu NY
J Clin Psychopharmacol; 2010 Jun; 30(3):230-4. PubMed ID: 20473056
[TBL] [Abstract][Full Text] [Related]
26. Neuroleptics and alternative treatments. Management of behavioral symptoms and psychosis in Alzheimer's disease and related conditions.
Wragg RE; Jeste DV
Psychiatr Clin North Am; 1988 Mar; 11(1):195-213. PubMed ID: 2898133
[TBL] [Abstract][Full Text] [Related]
27. Early onset of antipsychotic response in the treatment of acutely agitated patients with psychotic disorders.
Agid O; Kapur S; Warrington L; Loebel A; Siu C
Schizophr Res; 2008 Jul; 102(1-3):241-8. PubMed ID: 18495436
[TBL] [Abstract][Full Text] [Related]
28. Are low doses of antipsychotics effective in the management of psychomotor agitation? A randomized, rated-blind trial of 4 intramuscular interventions.
Mantovani C; Labate CM; Sponholz A; de Azevedo Marques JM; Guapo VG; de Simone Brito dos Santos ME; Pazin-Filho A; Del-Ben CM
J Clin Psychopharmacol; 2013 Jun; 33(3):306-12. PubMed ID: 23609398
[TBL] [Abstract][Full Text] [Related]
29. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
[TBL] [Abstract][Full Text] [Related]
30. Intramuscular ziprasidone treatment of acute psychotic agitation in elderly patients with schizophrenia.
Barak Y; Mazeh D; Plopski I; Baruch Y
Am J Geriatr Psychiatry; 2006 Jul; 14(7):629-33. PubMed ID: 16816018
[TBL] [Abstract][Full Text] [Related]
31. Initial treatment of severe acute psychosis with fast orally disintegrating risperidone tablets.
Normann C; Schmauss M; Bakri N; Gerwe M; Schreiner A
Pharmacopsychiatry; 2006 Nov; 39(6):209-12. PubMed ID: 17124642
[TBL] [Abstract][Full Text] [Related]
32. Psychotic symptoms, aggression and restlessness in dementia.
Ballard C; Gray A; Ayre G
Rev Neurol (Paris); 1999; 155 Suppl 4():S44-52. PubMed ID: 10637938
[TBL] [Abstract][Full Text] [Related]
33. Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice.
Goodwin G; Fleischhacker W; Arango C; Baumann P; Davidson M; de Hert M; Falkai P; Kapur S; Leucht S; Licht R; Naber D; O'Keane V; Papakostas G; Vieta E; Zohar J
Eur Neuropsychopharmacol; 2009 Jul; 19(7):520-32. PubMed ID: 19411165
[TBL] [Abstract][Full Text] [Related]
34. The role of typical and atypical antipsychotic medications in the management of agitation and aggression.
Buckley PF
J Clin Psychiatry; 1999; 60 Suppl 10():52-60. PubMed ID: 10340688
[TBL] [Abstract][Full Text] [Related]
35. Droperidol vs. haloperidol in the initial management of acutely agitated patients.
Resnick M; Burton BT
J Clin Psychiatry; 1984 Jul; 45(7):298-9. PubMed ID: 6376480
[TBL] [Abstract][Full Text] [Related]
36. Systematic reviews of assessment measures and pharmacologic treatments for agitation.
Zeller SL; Rhoades RW
Clin Ther; 2010 Mar; 32(3):403-25. PubMed ID: 20399981
[TBL] [Abstract][Full Text] [Related]
37. Pharmacological management of acutely agitated schizophrenic patients.
San L; Arranz B; Escobar R
Curr Pharm Des; 2005; 11(19):2471-7. PubMed ID: 16026300
[TBL] [Abstract][Full Text] [Related]
38. Dementia update. Pharmacologic management of agitation and psychosis in older demented patients.
Zaraa AS
Geriatrics; 2003 Oct; 58(10):48-50, 52-3. PubMed ID: 14569642
[No Abstract] [Full Text] [Related]
39. A markov model of the cost effectiveness of olanzapine treatment for agitation and psychosis in Alzheimer's disease.
Kirbach S; Simpson K; Nietert PJ; Mintzer J
Clin Drug Investig; 2008; 28(5):291-303. PubMed ID: 18407715
[TBL] [Abstract][Full Text] [Related]
40. Sustaining short-term gains for future progress.
Cañas F
Int Clin Psychopharmacol; 2001 Jan; 16 Suppl 1():S9-13. PubMed ID: 11252525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
